Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 87

1.

A retrospective epidemiologic study to define risk factors, microbiology, and clinical outcomes of infective endocarditis in a large tertiary-care teaching hospital.

Mostaghim AS, Lo HYA, Khardori N.

SAGE Open Med. 2017 Nov 13;5:2050312117741772. doi: 10.1177/2050312117741772. eCollection 2017.

2.

Legionnaire's Disease and Immunosuppressive Drugs.

Htwe TH, Khardori NM.

Infect Dis Clin North Am. 2017 Mar;31(1):29-42. doi: 10.1016/j.idc.2016.10.003. Epub 2016 Dec 12. Review.

PMID:
27979686
4.

Efficacy of selected biocides in the decontamination of common nosocomial bacterial pathogens in biofilm and planktonic forms.

El-Azizi M, Farag N, Khardori N.

Comp Immunol Microbiol Infect Dis. 2016 Aug;47:60-71. doi: 10.1016/j.cimid.2016.06.002. Epub 2016 Jun 18.

PMID:
27477508
5.

Nutrition in Wound Care Management: A Comprehensive Overview.

Quain AM, Khardori NM.

Wounds. 2015 Dec;27(12):327-35. Review.

6.

Evaluation of regional antibiograms to monitor antimicrobial resistance in Hampton Roads, Virginia.

Var SK, Hadi R, Khardori NM.

Ann Clin Microbiol Antimicrob. 2015 Apr 9;14:22. doi: 10.1186/s12941-015-0080-6.

7.
8.

Comparison of the Immunogenicity of Various Booster Doses of Inactivated Polio Vaccine Delivered Intradermally Versus Intramuscularly to HIV-Infected Adults.

Troy SB, Kouiavskaia D, Siik J, Kochba E, Beydoun H, Mirochnitchenko O, Levin Y, Khardori N, Chumakov K, Maldonado Y.

J Infect Dis. 2015 Jun 15;211(12):1969-76. doi: 10.1093/infdis/jiu841. Epub 2015 Jan 7.

9.

Future of diagnostic microbiology.

Khardori N.

Indian J Med Microbiol. 2014 Oct-Dec;32(4):371-7. doi: 10.4103/0255-0857.142233. Review.

10.

Overwhelming Capnocytophaga canimorsus infection in a patient with asplenia.

Shahani L, Khardori N.

BMJ Case Rep. 2014 Apr 23;2014. pii: bcr2013202768. doi: 10.1136/bcr-2013-202768.

11.

Medical Clinics of North America. Interventions in infectious disease emergencies. Preface.

Khardori NM.

Med Clin North Am. 2012 Nov;96(6):xi-xii. doi: 10.1016/j.mcna.2012.09.004. Epub 2012 Sep 29. No abstract available.

PMID:
23102487
12.

Necrotizing soft-tissue infections.

Mullangi PK, Khardori NM.

Med Clin North Am. 2012 Nov;96(6):1193-202. doi: 10.1016/j.mcna.2012.08.003. Review.

PMID:
23102484
13.

Intra-abdominal and pelvic emergencies.

Singh S, Khardori NM.

Med Clin North Am. 2012 Nov;96(6):1171-91. doi: 10.1016/j.mcna.2012.09.002. Review.

PMID:
23102483
14.

Cardiac emergencies: infective endocarditis, pericarditis, and myocarditis.

Htwe TH, Khardori NM.

Med Clin North Am. 2012 Nov;96(6):1149-69. doi: 10.1016/j.mcna.2012.09.003. Review.

PMID:
23102482
15.

Immunotherapy in clinical medicine.

Khardori NM, Khardori R.

Med Clin North Am. 2012 May;96(3):xiii-xiv. doi: 10.1016/j.mcna.2012.04.005. Epub 2012 Apr 17. No abstract available.

PMID:
22703860
16.

Immunotherapies in infectious diseases.

Kak V, Sundareshan V, Modi J, Khardori NM.

Med Clin North Am. 2012 May;96(3):455-74, ix. doi: 10.1016/j.mcna.2012.04.002. Epub 2012 May 1. Review.

PMID:
22703851
17.

Immunotherapy in clinical medicine: historical perspective and current status.

Shahani L, Singh S, Khardori NM.

Med Clin North Am. 2012 May;96(3):421-31, ix. doi: 10.1016/j.mcna.2012.04.001. Epub 2012 May 9. Review.

PMID:
22703849
19.

Mycobacteria and biological response modifiers: two sides of the relationship.

Sundareshan V, Modi J, Khardori NM.

Infect Dis Clin North Am. 2011 Dec;25(4):865-93. doi: 10.1016/j.idc.2011.07.010. Review.

PMID:
22054761
20.

Fusobacterium necrophorum--beyond Lemierres syndrome.

Shahani L, Khardori N.

BMJ Case Rep. 2011 Nov 15;2011. pii: bcr0720114527. doi: 10.1136/bcr.07.2011.4527.

21.

Pharmaco-EcoMicrobiology: a newer component of medical sciences bridging pharmacovigilance, ecology, and environmental microbiology.

Shahid M, Khardori N, Tripathi T, Bergman S.

J Infect Public Health. 2010;3(1):1-4. doi: 10.1016/j.jiph.2009.11.001. Epub 2010 Feb 1.

22.

Vancomycin-induced thrombocytopenia in a 60-year-old man: a case report.

Shah RA, Musthaq A, Khardori N.

J Med Case Rep. 2009 Jun 26;3:7290. doi: 10.4076/1752-1947-3-7290.

23.

Interferon-gamma receptors in HIV-1 infection.

Koirala J, Adamski A, Koch L, Stueber D, El-Azizi M, Khardori NM, Ghassemi M, Novak RM.

AIDS Res Hum Retroviruses. 2008 Aug;24(8):1097-102. doi: 10.1089/aid.2007.0261.

PMID:
18620489
24.

Teaching NeuroImage: Oculomasticatory myorhythmia: pathognomonic phenomenology of Whipple disease.

Revilla FJ, de la Cruz R, Khardori N, Espay AJ.

Neurology. 2008 Feb 5;70(6):e25. doi: 10.1212/01.wnl.0000287142.16160.0f. No abstract available.

PMID:
18250283
25.

Fever of unknown origin in the returning traveler.

Speil C, Mushtaq A, Adamski A, Khardori N.

Infect Dis Clin North Am. 2007 Dec;21(4):1091-113, x. Review.

PMID:
18061090
26.

Granulocyte colony-stimulating factor dosing in pegylated interferon alpha-induced neutropenia and its impact on outcome of anti-HCV therapy.

Koirala J, Gandotra SD, Rao S, Sangwan G, Mushtaq A, Htwe TH, Adamski A, Blessman D, Khardori NM.

J Viral Hepat. 2007 Nov;14(11):782-7.

PMID:
17927614
27.

Infection in the elderly.

Htwe TH, Mushtaq A, Robinson SB, Rosher RB, Khardori N.

Infect Dis Clin North Am. 2007 Sep;21(3):711-43, ix. Review.

PMID:
17826620
28.

Infections in diabetes mellitus and hyperglycemia.

Gupta S, Koirala J, Khardori R, Khardori N.

Infect Dis Clin North Am. 2007 Sep;21(3):617-38, vii. Review.

PMID:
17826615
29.

Infection, immunity, and hormones/endocrine interactions.

Khardori R, Adamski A, Khardori N.

Infect Dis Clin North Am. 2007 Sep;21(3):601-15, vii. Review.

PMID:
17826614
30.

Candida albicans Als proteins mediate aggregation with bacteria and yeasts.

Klotz SA, Gaur NK, De Armond R, Sheppard D, Khardori N, Edwards JE Jr, Lipke PN, El-Azizi M.

Med Mycol. 2007 Jun;45(4):363-70.

PMID:
17510860
31.

Antibiotics--past, present, and future.

Khardori N.

Med Clin North Am. 2006 Nov;90(6):1049-76. Review.

PMID:
17116436
32.

Category C potential bioterrorism agents and emerging pathogens.

Mushtaq A, El-Azizi M, Khardori N.

Infect Dis Clin North Am. 2006 Jun;20(2):423-41, x. Review. No abstract available.

PMID:
16762745
33.

Anthrax: from antiquity and obscurity to a front-runner in bioterrorism.

Kyriacou DN, Adamski A, Khardori N.

Infect Dis Clin North Am. 2006 Jun;20(2):227-51, viii. Review. No abstract available.

PMID:
16762737
34.

Bioterrorism and bioterrorism preparedness: historical perspective and overview.

Khardori N.

Infect Dis Clin North Am. 2006 Jun;20(2):179-211, vii. No abstract available.

PMID:
16762735
35.

Bioterrorism and bioterrorism preparedness.

Khardori N.

Infect Dis Clin North Am. 2006 Jun;20(2):xiii-xv. No abstract available.

PMID:
16762734
36.

Evaluating antibiograms to monitor drug resistance.

El-Azizi M, Mushtaq A, Drake C, Lawhorn J, Barenfanger J, Verhulst S, Khardori N.

Emerg Infect Dis. 2005 Aug;11(8):1301-2.

37.

Comparison of antimicrobial impregnation with tunneling of long-term central venous catheters: a randomized controlled trial.

Darouiche RO, Berger DH, Khardori N, Robertson CS, Wall MJ Jr, Metzler MH, Shah S, Mansouri MD, Cerra-Stewart C, Versalovic J, Reardon MJ, Raad II.

Ann Surg. 2005 Aug;242(2):193-200.

38.

In vitro activity of vancomycin, quinupristin/dalfopristin, and linezolid against intact and disrupted biofilms of staphylococci.

El-Azizi M, Rao S, Kanchanapoom T, Khardori N.

Ann Clin Microbiol Antimicrob. 2005 Jan 7;4:2.

39.

Interactions of Candida albicans with other Candida spp. and bacteria in the biofilms.

El-Azizi MA, Starks SE, Khardori N.

J Appl Microbiol. 2004;96(5):1067-73.

40.

Improved outcomes associated with limiting identification of Candida spp. in respiratory secretions.

Barenfanger J, Arakere P, Cruz RD, Imran A, Drake C, Lawhorn J, Verhulst SJ, Khardori N.

J Clin Microbiol. 2003 Dec;41(12):5645-9.

41.

Transient parkinsonism in West Nile virus encephalitis.

Robinson RL, Shahida S, Madan N, Rao S, Khardori N.

Am J Med. 2003 Aug 15;115(3):252-3. No abstract available.

PMID:
12935837
42.

Treatment of central nervous system infection by vancomycin-resistant enterococcus faecium.

Kanchanapoom T, Koirala J, Goodrich J, Agamah E, Khardori N.

Diagn Microbiol Infect Dis. 2003 Mar;45(3):213-5.

PMID:
12663164
43.

Interaction between biofilms formed by Staphylococcus epidermidis and quinolones.

Yassien M, Khardori N.

Diagn Microbiol Infect Dis. 2001 Jul;40(3):79-89.

PMID:
11502373
44.

Factors influencing adherence of Candida spp. to host tissues and plastic surfaces.

el-Azizi M, Khardori N.

Indian J Exp Biol. 1999 Oct;37(10):941-51. Review.

PMID:
10783751
45.

Hydroxyurea toxicity in human immunodeficiency virus-positive patients.

Goodrich J, Khardori N.

Clin Infect Dis. 1999 Sep;29(3):692-3. No abstract available.

PMID:
10530476
46.

Valvular and myocardial abscesses due to Erysipelothrix rhusiopathiae.

Nandish S, Khardori N.

Clin Infect Dis. 1999 Nov;29(5):1351-2. No abstract available.

PMID:
10525004
47.

A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group.

Darouiche RO, Raad II, Heard SO, Thornby JI, Wenker OC, Gabrielli A, Berg J, Khardori N, Hanna H, Hachem R, Harris RL, Mayhall G.

N Engl J Med. 1999 Jan 7;340(1):1-8.

48.

Cytomegalovirus: the taming of the beast?

Goodrich J, Khardori N.

Lancet. 1997 Dec 13;350(9093):1718-9. No abstract available.

PMID:
9413457
49.

Modulation of biofilms of Pseudomonas aeruginosa by quinolones.

Yassien M, Khardori N, Ahmedy A, Toama M.

Antimicrob Agents Chemother. 1995 Oct;39(10):2262-8.

50.

Tolerance of Staphylococcus epidermidis grown from indwelling vascular catheters to antimicrobial agents.

Khardori N, Yassien M, Wilson K.

J Ind Microbiol. 1995 Sep;15(3):148-51.

PMID:
8519470

Supplemental Content

Loading ...
Support Center